We specialize in the health sector and the pharmaceutical industry. Over many years, we have gained the trust of many clients, carrying out dozens of projects and many trainings for them. We operate mainly on behalf of the pharmaceutical industry, we have carried out many unusual projects and conducted unique trainings. Many drug manufacturers and other healthcare institutions have trusted us. We focus on an innovative approach to the tasks entrusted to us and continuous development. We offer:
72.19.Z - Scientific research and development activities
18.13.Z - Service activities related to printing preparation
58.19.Z - Other publishing activities, excluding software publishing
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,4 | -0,1 | -130,5 |
Gross profit (loss) | 0,2 | 0,4 | -0,1 | -136,1 |
EBITDA | 0,3 | 0,4 | -0,1 | -134,6 |
Short time liabilities | 0,1 | 0,2 | 0,3 | 35,4 |
Other operating costs | 0 | 0 | 0 | -79,6 |
Equity capital | 0,2 | 0,4 | 0,3 | -29 |
Operating profit (EBIT) | 0,3 | 0,4 | -0,1 | -134,6 |
Assets | 0,4 | 0,6 | 0,6 | -9,9 |
Net profit (loss) | 0,2 | 0,3 | -0,1 | -140,1 |
Cash | 0,1 | 0,1 | 0 | -92 |
Net income from sale | 1,2 | 1,7 | 1 | -42,4 |
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,3 | 35,4 |
Working assets | 0,4 | 0,6 | 0,6 | -9,9 |
Other income costs | 0 | 0 | 0 | 93 650 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 89 | 72,2 | -40,8 | -113 |
Equity capital to total assets | 64,4 | 70,4 | 55,5 | -14,9 |
Gross profit margin | 20,2 | 20,3 | -12,7 | -33 |
EBITDA Margin | 21,2 | 20,8 | -12,5 | -33,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 39 | 91 | 52 |
Current financial liquidity indicator | 2.8051445484161377 | 3.3796098232269287 | 2.2483158111572266 | -1,2 |
Net dept to EBITDA | -0.5185370445251465 | -0.23028618097305298 | -0.20383939146995544 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane